Trials / Active Not Recruiting
Active Not RecruitingNCT04866680
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Personalized Circulating DNA Follow-up in Melanoma
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 136 (actual)
- Sponsor
- Institut de Cancérologie de Lorraine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
PERCIMEL is an open multicentric study. The purpose of this study is to assess the interest of molecular analysis on circulating tumor DNA in the follow-up of the disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Personalized Circulating DNA follow-up | FFPE tissue sample will be collected before and after surgery blood samples will be collected before and after surgery and every 3 to 4 months |
Timeline
- Start date
- 2023-01-31
- Primary completion
- 2027-11-01
- Completion
- 2028-11-01
- First posted
- 2021-04-30
- Last updated
- 2026-02-09
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04866680. Inclusion in this directory is not an endorsement.